Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 4, 2010
Substantia nigra echogenicity in progressive supranuclear palsy
Jens Ebentheuer, Monica Canelo, Ellen Trautmann, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort
Sebastian Schade, Friederike Sixel-Döring, Jens Ebentheuer, et al.
Acta Neuropathologica
|
May 3, 2014
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology
Kathrin Doppler, Sönke Ebert, Nurcan Uçeyler, et al.
CNS Drugs
|
November 16, 2017
Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy
Saskia Müller-Rebstein, Claudia Trenkwalder, Jens Ebentheuer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 16, 2015
Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy
Kathrin Doppler, Jessica Weis, Katharina Karl, et al.
Neuroscience Letters
|
November 15, 2012
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
Brit Mollenhauer, Ellen Trautmann, Peggy Taylor, et al.
Journal of Parkinson'S Disease
|
November 1, 2021
Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease
Michael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Human Brain Mapping
|
January 20, 2011
Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls
Niels K Focke, Gunther Helms, Sebstian Scheewe, et al.
Neurology
|
May 11, 2016
Monitoring of 30 marker candidates in early Parkinson disease as progression markers
Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 4, 2010
Substantia nigra echogenicity in progressive supranuclear palsy
Jens Ebentheuer, Monica Canelo, Ellen Trautmann, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort
Sebastian Schade, Friederike Sixel-Döring, Jens Ebentheuer, et al.
Acta Neuropathologica
|
May 3, 2014
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology
Kathrin Doppler, Sönke Ebert, Nurcan Uçeyler, et al.
CNS Drugs
|
November 16, 2017
Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy
Saskia Müller-Rebstein, Claudia Trenkwalder, Jens Ebentheuer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 16, 2015
Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy
Kathrin Doppler, Jessica Weis, Katharina Karl, et al.
Neuroscience Letters
|
November 15, 2012
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
Brit Mollenhauer, Ellen Trautmann, Peggy Taylor, et al.
Journal of Parkinson'S Disease
|
November 1, 2021
Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease
Michael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Human Brain Mapping
|
January 20, 2011
Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls
Niels K Focke, Gunther Helms, Sebstian Scheewe, et al.
Neurology
|
May 11, 2016
Monitoring of 30 marker candidates in early Parkinson disease as progression markers
Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Page
of 2